SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as the community highlights its transition into a global "phygital" brand with successful retail toy sales and increased mainstream exposure. While investors debate the project's bottom and long-term potential compared to other memecoins, excitement is building around recent high-profile marketing campaigns, such as the Las Vegas Sphere display, and ongoing discussions regarding its utility and revenue growth.

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is attracting significant interest as a specialized infrastructure play, with the community highlighting its focus on secure data validation, enterprise-grade scalability, and established relationships with government and defense sectors. Investors are particularly focused on the project's ability to provide tamper-proof data pipelines for AI and IoT, distinguishing it from general-purpose L1 blockchains through its metagraph architecture.

GALA is designed to power the Gala Games ecosystem to support gaming re-imagined to benefit creators and players, alike.

Gala Games

Gala Games is experiencing intense community debate, with bulls citing potential in blockchain gaming, stablecoin integration, and entertainment platforms, while skeptics point to historical price struggles and perceived project stagnation. Investors are actively monitoring key technical support levels and broader altcoin market trends, weighing long-term utility against frustrations over past token performance.

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Bicycle Therapeutics Plc - ADR

Bicycle Therapeutics is currently in the spotlight as investors await critical H1 2026 data readouts, including BT5528 combination results at the upcoming AACR conference. The community remains highly focused on the company's recent strategic pivot, which includes a significant workforce reduction and a prioritized shift toward their radioconjugate pipeline and EphA2-targeting assets.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is attracting significant attention as investors track its progress with the Phase 2 LOTUS trial for the treatment of hidradenitis suppurativa. The community is actively discussing the company's clinical milestones, analyst ratings, and the potential for a major re-rating as the market awaits upcoming data readouts.

Maul Coin

Maul Coin is generating significant buzz as a community-driven project that is rallying its supporters to push for increased visibility and a breakout move. The community remains highly active in defending the token against bot manipulation and profit-taking, while focusing on long-term growth and potential exchange listings.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is trending as community members closely watch ongoing legal proceedings involving Craig Wright and the COPA litigation, which has reignited intense debate regarding the project's origins and its status as the original Bitcoin protocol. While many investors are expressing frustration over the recent court developments and price stagnation, a vocal segment of the community remains committed to the asset, citing its technical capability for high-volume, low-cost transactions as a superior alternative to other blockchain networks.

Monero

Monero is trending as the community debates its utility as a premier privacy-focused store of value compared to other major crypto assets. Investors are actively discussing the coin's long-term potential for anonymity and its resilience, even as it faces ongoing regulatory scrutiny and delistings from various exchanges.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing heightened community debate as investors weigh the potential for long-term integration and ecosystem expansion against ongoing frustration with lagging price performance. While some participants continue to accumulate and maintain a long-term conviction, others are actively questioning the project's momentum and comparing it unfavorably to newer market entrants.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph is capturing attention as developers and institutional investors focus on its role in providing essential Web3 data indexing for AI and decentralized protocols. While some community members remain frustrated by price volatility and historical dilution, bulls are aggressively accumulating the asset, citing its integration with major blockchains and expectations for infrastructure-led growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK Pharma Slapped Rs 23.21 Crore Tax Demand, Plans Appeal

Mumbai: GlaxoSmithKline Pharmaceuticals Limited (GSK Pharma ) has received a tax demand of Rs 23.21 crore from the Income Tax Department following a scrutiny assessment for the Assessment Year 2023-24.

GST Blow: Maharashtra Authorities Slap Rs 6.92 Crore Tax Demand on GSK Pharma

New Delhi: GlaxoSmithKline Pharmaceuticals Limited has received a tax demand … portal and was received physically. GlaxoSmithKline Pharmaceuticals Limited stated that the tax demand …

MP GST Dept Slaps Rs 3.79 Crore Tax, Penalty Demand on GSK Pharma

New Delhi: GlaxoSmithKline Pharmaceuticals Limited has received … and documentation requirements. GlaxoSmithKline (GSK) Pharmaceuticals Limited clarified in its … appropriate action as necessary. GlaxoSmithKline Pharmaceuticals Limited, the Indian subsidiary …

GSK India plans big 'reinvention'

Mumbai: Global biopharma major GlaxoSmithKline Pharmaceuticals, best known in India for its blockbuster legacy brands Augmentin and Calpol, is charting a bold comeback in the country. The London-headquartered company, which has completed over a century in India's pharma market, is plotting its most ambitious transformation in decades as it targets doubling its India revenue to ₹8,000 crore within 4-5 years, India MD Bhushan Akshikar told ET in an exclusive interview.This will be driven by a strategic pivot from its ₹4,000-crore base of legacy portfolio of general medicines-including medications in anti-infective, pain management, respiratory and vaccines-into specialty drugs in high-growth areas of oncology and liver diseases as well as nascent areas such as adult vaccination."Reinvention and impact are the two words that define our journey in India. Taking cue from our past but remaining completely focused on the future is how I see the next decade for us," said Akshikar. "Our base business will continue to grow while on top of that we are launching in areas where we can make a sizeable impact," he added.The bet will be on innovation-led growth, accelerated clinical trials in India, and concurrent launches of global assets to double size by the end of the decade.

GSK Pharma to Procure 4.95 MWp Solar Power from CleanMax in Maharashtra

GlaxoSmithKline Pharmaceuticals (GSK Pharma ) will procure 4.95 MWp … , Syngene International, a Bengaluru-based pharmaceutical company, announced procuring renewable energy … February 2025, Mumbai-based Aarti Drugs partnered with Prozeal Green Energy …

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.

GLAXO.NSE
GlaxoSmithkline Pharmaceuticals Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest GLAXO.NSE News

GLAXO.NSEGlaxoSmithkline Pharmaceuticals Ltd